Nephrology Flashcards

1
Q

common causes of non-gap metabolic acidosis

A
acetazolamide
topiramate
chemotherapy- ex cisplatin
abx- aminoglycosides, bactrim
amphotericin b
lithium
rifampin
inhaled toluene
pentamidine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

medical management of bilateral RAS

A
  • ACE/ARB and diuretic

- do this prior to considering angiography and stenting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

causes of AIN

A

drugs- abx, NSAIDS, PPIs
infections- legionella, strep
- systemic/autoimmune disease- ex. sjogrens, SLE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

clinical features and lab findings of AIN

A

rash, fever, allergic sx.
new drug exposure
eosinophilia or urinary eosinophils, though these are not necessary
urine sediment with pyuria, WBC casts, hematuria, varying proteinuria, however can also be normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ESRD daily phos restriction?

A

900 mg/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ESRD choice of phos binder?

A

if Ca <9.5, calcium carbonate or acetate

> 9.5, sevelamer or lanthanum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

if ESRD patient is restricting dietary phos, on a phos binder, and PTH remains >300, what next?

A

if serum phos <5.5, and serum ca<9.5 –> vit D analog

if serum phos <5.5 and serum ca>9.5, or if serum phos is >5.5 –> cinacalcet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do calcimimetics like cinacalcet work?

A

increase the sensitivity of calcium sensing receptors on parathyroid glands and reduce serum PTH, ca and phos

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

pathology findings of HSP in kidneys?

A

IgA immune complex deposition in small vessels and mesangium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how does malabsorption in bariatric surgery pts or those with small bowel malabsorption issues lead to increased risk of kidney stones?

A

increased urinary oxalate: fat binds to calcium and leaves oxalate to be renally excreted or absorbed by colon

low urinary citrate: unclear pathophys, may be 2/2 hypokalemia leading to increased citrate absorption in kidney. citrate is an inhibitor of kidney stones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How does polyoma virus (BK type) present in renal transplant pts?

A

most commonly after rejection and significant immunosuppression

patients develop tubulointerstitial nephritis w/ rising creatinine and intranuclear inclusions in urine cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

clinical features of goodpasture syndrome?

A

pulmonary hemorrhage and glomerulonephritis

anti-GBM ab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

dietary interventions to reduce risk of calcium oxalate kidney stones?

A
decrease sodium
decrease animal protein
increase calcium- dietary, not supplemental (decreases oxalate absorption in GI tract)
increase fluids
increase citrate/fruits and vegetables
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

extrarenal manifestations of polycystic kidney disease

A

hepatic cysts, pancreatic cysts, cerebral aneurysms, cardiac valvular disease and diverticulosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

metabolic acidosis algorithm:

high anion gap w/ ketones

A

DKA
starvation
EtOH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

metabolic acidosis algorithm:

high anion gap, neg ketones

A

check serum osm:
high: methanol, ethylene glycol

normal: salicylate, paraldehyde

17
Q

metabolic acidosis algorithm:
normal anion gap
negative urine anion gap

A

GI losses- diarrhea, laxative abuse

enteric fistulas

18
Q

metabolic acidosis algorithm:
normal anion gap
positive urine anion gap

A

renal bicarb losses: RTA, carbonic anhydrase inhibitors, low aldosterone state

19
Q

renal abnormalities in pts with sickle cell trait

A

hematuria and inability to concentrate urine

development of renal medullary carcinoma